【结 构 式】 |
【分子编号】35560 【品名】(1R,2S,6R,8R)-4-[(1S)-4-bromo-1-chlorobutyl]-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane 【CA登记号】 |
【 分 子 式 】C14H23BBrClO2 【 分 子 量 】349.50312 【元素组成】C 48.11% H 6.63% B 3.09% Br 22.86% Cl 10.14% O 9.16% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(VI)The preparation of the intermediate aminoboronate (VII) is shown in Scheme 27968701a. Addition of catecholborane (II) to allyl bromide (I) provided boronic ester (III). Subsequent exchange with (+)-alpha-pinanediol (IV) afforded the chiral borane (V). Insertion of dichloromethyllithium in (V) produced the alpha-chloroboronic ester (VI). The required amino compound was then obtained by displacement of the halogen with lithium hexamethyldisilazide, followed by acid-catalyzed desilylation.
【1】 Verbeuren, T.; Rupin, A.; De Nanteuil, G.; Gloanec, P.; New dicarbonyl cycloalkyl based thrombin inhibitors with improved activity and selectivity compared to (D)-Phe-Pro-boroArg derivatives . 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 201. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11463 | 3-Bromo-1-propene; 3-Bromopropene;allyl bromide | 106-95-6 | C3H5Br | 详情 | 详情 |
(II) | 32533 | 1,3,2-benzodioxaborole | 274-07-7 | C6H5BO2 | 详情 | 详情 |
(III) | 35558 | 2-(3-bromopropyl)-1,3,2-benzodioxaborole | C9H10BBrO2 | 详情 | 详情 | |
(IV) | 32535 | (1R,2S,3R,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol | C10H18O2 | 详情 | 详情 | |
(V) | 35559 | (1R,2S,6R,8R)-4-(3-bromopropyl)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane | C13H22BBrO2 | 详情 | 详情 | |
(VI) | 35560 | (1R,2S,6R,8R)-4-[(1S)-4-bromo-1-chlorobutyl]-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane | C14H23BBrClO2 | 详情 | 详情 | |
(VII) | 35561 | (1R)-4-bromo-1-[(1R,2S,6R,8R)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]-1-butanamine; (1R)-4-bromo-1-[(1R,2S,6R,8R)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butylamine | C14H25BBrNO2 | 详情 | 详情 |
Extended Information